Pharmacobezoar in a patient operated on for pyloric stenosis;Farmacobezoar en un paciente intervenido de estenosis pilórica

Farmacia Hospitalaria

Volumn 28, Issue 1, 2004, Pages 59-63

  Marín Pozo, Juan Francisco ^a   Soriano Martinez M ^a   Caba Porras, I ^a   Rodriguez Torne G ^a   Castelo Luque, A ^a  

^a Servicio de Cardiologia   (Spain)

Author keywords

Adverse effects; Bezoar; Delayed action preparations; Nifedipine

Indexed keywords

ADALAT OROS; NIFEDIPINE;

AGED; ARTICLE; BEZOAR; CASE REPORT; DELAYED DRUG RELEASE; DIGESTION; DISEASE PREDISPOSITION; ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTESTINE OBSTRUCTION; PHARMACOBEZOAR; PYLORUS STENOSIS; RISK FACTOR; STOMACH OBSTRUCTION;

AGED; ANTACIDS; BEZOARS; BLOOD TRANSFUSION; CATHARTICS; CELLULOSE; DELAYED-ACTION PREPARATIONS; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HUMANS; MALE; NIFEDIPINE; POSTOPERATIVE COMPLICATIONS; PYLORIC STENOSIS; SOLUBILITY; STOMACH; SUCRALFATE; TABLETS;

EID: 2142771359     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Blasco MA, Zaragoza R, Málaga A, Alfonso V. Bezoar esofágico: una complicación excepcional de la nutrición enteral. Rev Clin Esp 1998; 198 (7): 487-8.
2. Niezabitowski LM, Nguyen BN, Gums JG. Extended-Release Nifedipine Bezoar Identified One Year After Discontinuation. Ann Pharmacother 2000; 34: 862-4.
3. Ku MT. Beozars. Clin Toxicol Review 1996; 18 (9). http://www. maripoisoncenter.com/ctr/9606bezoars.html. Edición electrónica. Acceso Marzo 2003.
4. Bezoares. Enfermedades del estómago y del duodeno. En Farreras-Rozman Medicina Interna vol I. 12 Edición. Barcelona: Doyma, S.A., 1992. p. 109-10.
5. Bezoares y Cuerpos Extraños. Capitulo 24 Manual Merck. En http://www.msd.es/publicaciones/mmerck/MM_03_24.htm. Acceso Marzo 2002.
6. Kuo JY. Nonoperative treatment of gastric bezoars using electrohydraulic lithotrpsy. Endoscopy 1999; 31 (5): 386-8.
7. Winkler WP, Saleh J. Metoclopramide in the treatment of gastric beozars. Am J Gastroenterol 1983; 78 (7): 403-504.
8. Zapater P, García LE, García AG. Sistema OROS: una nueva formulación para la liberación controlada de nifedipino. Farmacoterapia 1993; 10 (6): 262-8.
9. Taylor JR, Streetman DS, Castle SS. Medication Bezoars: A Literature Review and Report a Case. Ann Pharmacother 1998; 32: 940-6.
10. Stack PE, Thomas E. Pharmacobezoar: An Evolving New Entity. Dig Dis 1995; 13: 356-64.
11. Smitz S, Bonnet V, Delporte, JP. Severe gastrointestinal dysfunction and retention of extended release nifedipine tablets. J Am Geriatr Soc 1998; 46 (5): 656-7.
12. Kwon HY, Scott RL, Mulloy JP. Small bowel Procardia XL tablet bezoar mimicking cystic pneumotosis intestinalis. Abdom Imaging 1996; 21 (2): 142-4.
13. Georgopolulos S, Gerdes H. Retention of nifedipine extended release tabs in a patient with a colonic stricture. Am J Gastroenterol 1995; 90 (12): 2224-6.
14. Reid T, Rubins JB, Levine J, DeCelles J, Silvis, S. Colonic medication bezoar from extended-release nifedipine and procainamide. Arch Fam Med 1995; 4 (8): 715-7.
15. Prisant LM, Carr AA, Botini PB, Kaesemeyer WH. Nifedipine GITS (gastrointestinal therapeutics system) bezoar. Arch Intern Med 1991; 151 (9): 1868-9.
16. Shepherd MF. Bezoar formed by fragments of extended release nifedipine tablets. Clin Pharm 1993; 12: 849-52.
17. Buckley N, Dawson AH, Howarth D, Whyte IM. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium. Med J Aust 1993; 158 (3): 202-4.
18. Soporer KA, Manning JJ. Massive ingestion of sustained release verapamil with a concretion and bowel infarction. Ann Emerg Med 1993; 22 (3): 603-5.
19. Bernstein G, Jehle D, Bernaski E, Braen GR. Failure of gastric emptying and charcoal administration in fatal sustained-release theophylline overdose: pharmacobezoar formation. Ann Emerg Med 1992; 21 (11): 1388-90.
20. Cereda JM, Scott J, Quigley EM. Endoscopic removal of pharmacobezoar of slow release theophylline. Br Med J 1986; 293 (6555): 1143.
21. Thorley-Brown D, Galla JH, Williams PD, Kant KS, Rashkin M. Lithium toxicity asociated with a trichobezoar. Ann Intern Med 1992; 116 (9): 739-40.
22. Razafimahefa H, Mouterde O, Devaux AM. Bezoard Oesophagien chez un enfant traité par sucralfate. Arch Pediatr 1997; 4 (7): 659-61.
23. Strozik KS, Walele AH, Hoffman H. Bezoar in a preterm baby associated with sucralfate. Clin Pediatr (Phila) 1996; 35 (8): 423-4.
24. Guy C, Ollangnier M. Sucralfate and bezoars: data from the system of pharmacologic vigilance and review of the literature. Therapie 1999; 54 (1): 55-8.
25. Cremer SA. Esophageal beozar resulting from enteral feedings. JPEN J Parenter Enteral Nutr 1996; 20 (5): 371-3.
26. Krupp KB, Johns P, Troncoso V. Esophageal beozar formation in a tube-fed pattient receiving sucralfate and antiacid therapy. A case report. Gastroenterol Nurs 1995; 18 (2): 46-8.
27. Shueke M, Mihas AA. Esophageal bezoar due to sucralfate. Endoscopy 1991; 23 (5): 305-6.
28. Carrougher JG, Barrilleaux CN. Esophageal bezoars: the sucralith. Crit Care Med 1991; 19 (6): 837-9.
29. Anderson W, Weatheerstone G, Veal C. Esophageal medication bezoar in a patient reeceiving enteral feedings and sucralfate. Am J Gastroenterol 1989; 84 (2): 205-6.
30. Rosenberg HK. Antiacid Bezoar in a Premature Infant. Clin Pediatr (Phila) 1982; 21 (8): 503-4.
31. Kaplan M, Ozeri Y, Agranat A, Brisk R, Eylath U. Antiacid bezoar in a premature infant. Am J Perinatol 1995; 12 (2): 98-9.
32. Burruss GL, Van Voorst SJ, Crawford AJ, Bhattacharya SK. Small bowell obstruction from aan antiacid bezoar: a ranitidine-antiacid interaction? South Med J 1996; 79 (7): 917-8.
33. Pérez-Piqueras J, Silva C, Jaqueti J, Sáez MA, Martínez D, Santa JM, et al. Endoscopic Diagnosis and treatment of an Esopahgeal Bezoar Reuslting from Bulk Laxative Ingestion. Endoscopy 1994; 26: 718.
34. Angueira C, Kadakia S. Esophageal and duodenal bezoars from Perdiem. Gastrointestinal Endoscopy 1993; 39 (1): 110-1.
35. Agha FP, Nostrant TT, Fiddian-Green RG. "Giant Colonic Bezoar: " A Medication Bezoar Due to Psyllium Seed Husks. Am J Gastroenterol 1984; 79 (4): 319-21.
36. Brown DC, Doughty JC, George WD. Surgical treatment of oesophageal obstruction after ingestion of a granular laxative. Postgrad Med J 1999; 75 (880): 106.
37. Gayer G, Gotlieb WH, Apter S. Paraffin oil bezaor impacted in the small bowell: CT fingings. Br J Radiol 2000; 73: 1213-4.
38. Amidon GL, Dressman JB. Enteric Coated Aspirin circumventing Gastric Retention. J Rheumatol 1985; 12 (2): 387-8.
39. Bogacz K, Caldron P. Enteric-Coated Aspirin Bezoar: Elevation of Serum Salicylate Level by Barium Study. Am J Med 1987; 83: 783-6.
40. Hutter D, Akgun S, Ramamoorthy R, Dever L. Medication Bezoar and Esophagitis in a Patient with HIV Infection Receiving Combination Antiretroviral Therapy. Am J Med 2000; 108: 684-5.
41. Ray MJ, Padin R, Condie JD, Halls JM. Charcoal Bezoar: Small-Bowel Obstruction Secondary to Amitryptyline Overdose Therapy. Dig Dis Sci 1988; 33 (1): 106-7.